ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Clinical Practice Session

ANCA-Associated Vasculitis: Evidence and Uncertainties in Assessment and Management

October 24, 2024 | 04:30 PM - 06:00 PM

Location: Room 6A, Convention Center

Session Description

Assessment and management of ANCA-associated vasculitis (AAV) have improved in recent years. However, despite substantial evidence, not only do significant uncertainties exist, but more targeted and less toxic therapies are still needed. This session presents recent advances, outlines evidence and uncertainties, and examines unmet needs and future opportunities in AAV, focusing on the kidneys as a commonly affected end organ.

Learning Objective(s)

  • Discuss newer assessment tools for kidney risk in ANCA-associated glomerulonephritis
  • Develop a rational approach to acute management of AAV, while appreciating the uncertainties that exist
  • Describe current imprecision in the clinical and laboratory assessment of AAV disease activity, remission, and relapse
  • Identify new opportunities for improving the assessment and management of AAV

Learning Pathway(s)

  • Glomerular Diseases

Moderators

Presentations